Welcome to Deal Talk: Australian M&A Update, where our M&A team take a closer look at some of the key issues in Australia.


Defining Matters

Spotlight on Corporate M&A in Australia

Partners Kam Jamshidi and Nicole Pedler explore what the 2025 NBIO market reveals for bidders and targets in Australian public M&A.

HSF Kramer has deeply analysed non binding indicative offers in public deals to extract the key lessons for bidders and targets when formulating their M&A strategy.




Meet the team

Market leading Australian M&A experts

Meet our experts

Find a lawyer

Let’s connect